Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Net Revenue	$ 23,771	$ 18,691	$ 61,519	$ 53,497
Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	2,197	258	2,327	1,026
Concentrates Products
Disaggregation of Revenue [Line Items]
Net Revenue	21,574	18,433	59,192	52,471
U.S.
Disaggregation of Revenue [Line Items]
Net Revenue	19,741	17,292	53,798	48,331
U.S. | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	0	193	0	561
U.S. | Concentrates Products
Disaggregation of Revenue [Line Items]
Net Revenue	19,741	17,099	53,798	47,770
Rest of World
Disaggregation of Revenue [Line Items]
Net Revenue	4,030	1,399	7,721	5,166
Rest of World | Drug products
Disaggregation of Revenue [Line Items]
Net Revenue	2,197	65	2,327	465
Rest of World | Concentrates Products
Disaggregation of Revenue [Line Items]
Net Revenue	1,833	1,334	5,394	4,701
Product Sales – Point-in-time | Drug product sales
Disaggregation of Revenue [Line Items]
Net Revenue	0	193	0	834
Product Sales – Point-in-time | Concentrates product sales
Disaggregation of Revenue [Line Items]
Net Revenue	21,574	17,953	57,720	51,035
Product Sales – Point-in-time | U.S. | Drug product sales
Disaggregation of Revenue [Line Items]
Net Revenue	0	193	0	561
Product Sales – Point-in-time | U.S. | Concentrates product sales
Disaggregation of Revenue [Line Items]
Net Revenue	19,741	16,619	52,326	46,334
Product Sales – Point-in-time | Rest of World | Drug product sales
Disaggregation of Revenue [Line Items]
Net Revenue	0	0	0	273
Product Sales – Point-in-time | Rest of World | Concentrates product sales
Disaggregation of Revenue [Line Items]
Net Revenue	1,833	1,334	5,394	4,701
License Fee – Over time | Drug license fee
Disaggregation of Revenue [Line Items]
Net Revenue	2,197	65	2,327	192
License Fee – Over time | Concentrates product license fee
Disaggregation of Revenue [Line Items]
Net Revenue	0	480	1,472	1,436
License Fee – Over time | U.S. | Drug license fee
Disaggregation of Revenue [Line Items]
Net Revenue	0	0	0	0
License Fee – Over time | U.S. | Concentrates product license fee
Disaggregation of Revenue [Line Items]
Net Revenue	0	480	1,472	1,436
License Fee – Over time | Rest of World | Drug license fee
Disaggregation of Revenue [Line Items]
Net Revenue	2,197	65	2,327	192
License Fee – Over time | Rest of World | Concentrates product license fee
Disaggregation of Revenue [Line Items]
Net Revenue	$ 0	$ 0	$ 0	$ 0